About this trial
Traditional opioid analgesia is a treatment method for moderate to severe pain. However, the use of opioid drugs is not without risks. When treating acute pain, patients may experience hypotension, respiratory depression, hypoxia, nausea and vomiting, irritability, and itching. The purpose of this study is to evaluate the comparison of G protein biased μ - opioid receptor agonist oliceridine and traditional μ - opioid receptor agonist sufentanil in terms of analgesia in patients under general anesthesia.
Eligibility criteria
Qualifiers
Age>65 years old
ASA Level I-III
BMI 18.5-29.9
Patients undergoing knee joint surface replacement surgery under general anesthesia
Disqualifiers
Suffering from chronic pain or mental illness before surgery
Unable to communicate due to cognitive impairment or language barriers before surgery
Patients who have used opioid drugs three days before surgery
Patients with long-term alcohol consumption
Trial design
Treatments tested in this trial
- Oliceridine
- Sulfentanil